A retrospective chart review of trauma-related documentation in an Australian substance use treatment service.


Journal

Drug and alcohol review
ISSN: 1465-3362
Titre abrégé: Drug Alcohol Rev
Pays: Australia
ID NLM: 9015440

Informations de publication

Date de publication:
02 2023
Historique:
revised: 16 09 2022
received: 21 05 2022
accepted: 24 10 2022
pubmed: 16 11 2022
medline: 3 2 2023
entrez: 15 11 2022
Statut: ppublish

Résumé

Trauma exposure among clients of substance use treatment services is almost universal and rates of trauma-related symptoms are correspondingly high. This study examined one aspect of clinical care-clinical documentation-and sought to systematically assess the documentation of trauma-related comorbidities and their treatment in a substance use treatment setting. A retrospective chart review was conducted on a sample of 300 patient records in a public substance use treatment setting. Rates of documentation of trauma-related events, symptoms and treatment, along with variables influencing the documentation of these issues, were examined. Trauma-related documentation was present in 45.3% of records. There were documented trauma-related symptoms in 15.3% of records, although treatment activities addressing trauma were only present in 2.3% of records. Being female (odds ratio [OR] 2.58, 95% confidence interval [CI] 1.42, 4.69), having prior mental health treatment (OR 1.82, 95% CI 1.05, 1.12) and having more treatment sessions (OR 1.08, 95% CI = 1.05, 1.12) increased the odds of trauma-related documentation being present, while being in the first episode of treatment (OR 0.49, 95% CI = 0.28, 0.84) decreased the odds. This study highlights significant under documentation of trauma-related comorbidities in substance-use treatment. There is limited evidence of consideration of trauma-related symptoms or diagnoses, and trauma-related comorbidities are rarely included in treatment planning activities. The lack of documented trauma-related information has important clinical and medico-legal implications for patients, and provides evidence to suggest a lack of integration of treatment for trauma-related disorders in substance use settings.

Identifiants

pubmed: 36377196
doi: 10.1111/dar.13575
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

373-383

Subventions

Organisme : Matilda Centre PhD Scholarship
Organisme : Australian Government National Health and Medical Research Council Senior Research Fellowship
Organisme : Australian Government National Health and Medical Research Council Translating Research into Practice Fellowship

Informations de copyright

© 2022 The Authors. Drug and Alcohol Review published by John Wiley & Sons Australia, Ltd on behalf of Australasian Professional Society on Alcohol and other Drugs.

Références

Drug Alcohol Rev. 2015 May;34(3):252-8
pubmed: 25355060
Ment Health Fam Med. 2012 Sep;9(3):181-9
pubmed: 23997824
Subst Abuse Treat Prev Policy. 2019 May 29;14(1):23
pubmed: 31142336
Drug Alcohol Rev. 2017 Jul;36(4):527-539
pubmed: 27786426
Drug Alcohol Rev. 2012 May;31(3):294-302
pubmed: 21521385
Front Psychiatry. 2019 Oct 18;10:674
pubmed: 31681026
Am J Psychiatry. 2006 Apr;163(4):652-8
pubmed: 16585440
Aust N Z J Psychiatry. 2011 May;45(5):407-15
pubmed: 21189046
Aust N Z J Psychiatry. 1998 Apr;32(2):206-13
pubmed: 9588299
Drug Alcohol Rev. 2023 Feb;42(2):373-383
pubmed: 36377196
Psychol Trauma. 2018 Mar;10(2):229-238
pubmed: 28581317
Int J Ment Health Nurs. 2002 Jun;11(2):70-9
pubmed: 12430188
Drug Alcohol Depend. 2005 Mar 7;77(3):243-9
pubmed: 15734224
Drug Alcohol Rev. 2015 May;34(3):234-41
pubmed: 25737377
Eur J Psychotraumatol. 2014 Feb 05;5:
pubmed: 24511368
Child Abuse Negl. 2015 Jun;44:36-45
pubmed: 25636522
Community Ment Health J. 2022 Aug;58(6):1076-1087
pubmed: 35094164
Drug Alcohol Rev. 2017 May;36(3):317-324
pubmed: 27324816
Br J Psychiatry. 2010 Nov;197(5):378-85
pubmed: 21037215
Gen Hosp Psychiatry. 2019 May - Jun;58:33-38
pubmed: 30849678
Indian J Pediatr. 2012 Nov;79(11):1482-8
pubmed: 22562262
Psychiatr Serv. 2016 Aug 1;67(8):878-82
pubmed: 26975516
J Trauma Stress. 1997 Jan;10(1):141-8
pubmed: 9018685
Acta Psychiatr Scand. 2016 Oct;134(4):287-94
pubmed: 26852371
Int J Ment Health Nurs. 2017 Feb;26(1):95-104
pubmed: 27600259
J Ment Health. 2016 Aug;25(4):359-365
pubmed: 26850075
Psychiatr Serv. 1998 Mar;49(3):355-9
pubmed: 9525796
Harm Reduct J. 2016 Oct 12;13(1):29
pubmed: 27733167
Community Ment Health J. 2002 Aug;38(4):351-6
pubmed: 12166921
Int J Ment Health Nurs. 2018 Feb;27(1):7-19
pubmed: 28815844

Auteurs

Logan R Harvey (LR)

Matilda Centre for Research in Mental Health and Substance Use, The University of Sydney, Sydney, Australia.

Rachel Hopkins (R)

Drug Health, Western Sydney Local Health District, Sydney, Australia.

Melanie Truscott (M)

Drug Health, Western Sydney Local Health District, Sydney, Australia.

Christina Marel (C)

Matilda Centre for Research in Mental Health and Substance Use, The University of Sydney, Sydney, Australia.

Tim Slade (T)

Matilda Centre for Research in Mental Health and Substance Use, The University of Sydney, Sydney, Australia.

Katherine L Mills (KL)

Matilda Centre for Research in Mental Health and Substance Use, The University of Sydney, Sydney, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH